Cargando…
Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo
Background: Statin has been widely used to treat hyperlipidemia because of its high potency in decreasing cholesterol levels. The present study aimed to examine the lipid-lowering effect of rosuvastatin and the composition, diversity and species abundance of gut microbiome in association with rosuva...
Autores principales: | Liu, Yinhui, Song, Xiaobo, Zhou, Huimin, Zhou, Xue, Xia, Yunlong, Dong, Xin, Zhong, Wei, Tang, Shaoying, Wang, Lili, Wen, Shu, Xiao, Jing, Tang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874287/ https://www.ncbi.nlm.nih.gov/pubmed/29623075 http://dx.doi.org/10.3389/fmicb.2018.00530 |
Ejemplares similares
-
Rosuvastatin alters the genetic composition of the human gut microbiome
por: Kummen, Martin, et al.
Publicado: (2020) -
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
por: Saeedi, Ramesh, et al.
Publicado: (2015) -
Editorial: The potential role of gut microbiome in animal gut-linked diseases
por: Zhang, Hui, et al.
Publicado: (2023) -
Gut microbiome interacts with pregnancy hormone metabolites in gestational diabetes mellitus
por: Lyu, Xuejing, et al.
Publicado: (2023) -
Alterations of the Gut Microbiome in Hypertension
por: Yan, Qiulong, et al.
Publicado: (2017)